SNN - Smith & Nephew plc
43.90 +0.07 (0.16%)
Pre-Market: 7:13AM EDT
| Previous Close | 43.80 |
| Open | 43.78 |
| Bid | 43.83 x 800 |
| Ask | 43.89 x 1200 |
| Day's Range | 43.69 - 44.04 |
| 52 Week Range | 32.22 - 44.07 |
| Volume | 317,973 |
| Avg. Volume | 434,226 |
| Market Cap | 19.531B |
| Beta (3Y Monthly) | 0.14 |
| PE Ratio (TTM) | 28.95 |
| EPS (TTM) | 1.51 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.72 (1.64%) |
| Ex-Dividend Date | 2019-04-04 |
| 1y Target Est | 43.00 |
- Financial Times•8 hours ago
Smith & Nephew directors discussed US listing to boost CEO pay
Smith & Nephew board members have discussed moving the company’s share listing to the US, partly to escape the UK’s stricter attitude towards executive pay. According to two people familiar with the matter, the discussion over a listing change was prompted in part by efforts to narrow the gap between Mr Nawana’s pay at his former company Alere and his current role at the FTSE 100 medical devices maker, which he joined last May. As chief executive of Alere, a US medical diagnostics company, Mr Nawana earned a $8.6m pay package in 2016 and $11.1m in 2015.
- Financial Times•9 days ago
Namal Nawana: Sending shockwaves through Smith & Nephew
When Namal Nawana was wooed to take the top job at Smith & Nephew, he took a hard look at the venerable UK medical devices company and found both a puzzle and an opportunity. “The technologies themselves ...
- Simply Wall St.•11 days ago
Need To Know: Smith & Nephew plc (LON:SN.) Insiders Have Been Selling Shares
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
- American City Business Journals•12 days ago
DHL plans to add 50 jobs, invest millions of dollars in Memphis facilities
Logistics firm DHL Supply Chain will expand its medical device and pharmaceutical logistics business in Memphis, bringing about 50 more jobs and $8 million in capital investment.
- Zacks•18 days ago
Smith & Nephew (SNN) Buys Brainlab, Braces Robotic Ecosystem
The transaction by Smith & Nephew (SNN), besides the business purchase, comprises certain intangible assets and the orthopaedic Brainlab salesforce.
- Zacks•18 days ago
Titan Medical (TMDI) Shows Promise on Strategic Developments
Titan Medical (TMDI) is putting in a good deal of effort to strengthen its position in the multi-billion dollar computer-assisted robotic surgical technologies market.
- Reuters•19 days ago
INSIGHT-Will Europe's clampdown on faulty medical devices hurt patients?
When a Californian company founded by a U.S. veteran wounded in Afghanistan sought to register a new medical device this year, it turned to Europe before the United States. "Now it has flipped," said Bill Colone, CEO of San Clemente-based Spinal Singularity, which hopes to launch a 'smart' catheter for men with spinal injuries or disease early next year after squeezing in its application under the old European rules. Colone is part of a chorus of industry voices warning that a switch to stricter European rules governing medical devices, due to come into force a year from now, will slow or even halt the release of products in Europe that could transform patients' lives.
- PR Newswire•20 days ago
Smith & Nephew Launches the CONQUEST FN™ Femoral Neck Fracture System, a Fresh Approach to Hip Preservation Versus Current Treatment Options
LONDON , June 5, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, has announced the launch of its CONQUEST FN™ system, a new implant solution to treat femoral ...
- Simply Wall St.•26 days ago
Do Directors Own Smith & Nephew plc (LON:SN.) Shares?
A look at the shareholders of Smith & Nephew plc (LON:SN.) can tell us which group is most powerful. Insiders often...
- PR Newswire•last month
Smith & Nephew's OXINIUM™ Technology for Hips could save the US Health System an estimated $296 Million in 2020
LONDON , May 22, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today presented new data at the International Society for Pharmacoeconomics and Outcomes ...
- Simply Wall St.•last month
How Good Is Smith & Nephew plc (LON:SN.), When It Comes To ROE?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
- PR Newswire•last month
Smith & Nephew launches new FLOW 90™ Wand at ISAKOS joining its innovative collection of COBLATION™ technology and shoulder repair portfolios
LONDON , May 13, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, today announces the U.S. launch of the WEREWOLF™ FLOW 90 Wand with FLOW~IQ™ Technology. ...
- Business Wire•2 months ago
New NICE guidance recognises that Smith & Nephew’s PICO™ sNPWT provides better outcomes than standard dressings in patients at high risk of surgical site infections, at similar overall cost
Smith & Nephew , the global medical technology business, welcomes the launch of new medical technologies guidance from the UK National Institute for Health and Care Excellence .
- Reuters•2 months ago
Smith & Nephew lifts revenue view after best quarter since 2015
Emerging markets, especially China, have been a bright spot for the company as its mature markets, including the United States which accounts for about half of its revenue, stabilise after a shaky start to last year. Growth of 15.3 percent in emerging markets powered Smith & Nephew's total revenue to $1.20 billion (£919.4 million), in line with analysts' expectations, according to a company-compiled consensus http://www.smith-nephew.com/investor-centre/reporting/analyst-consensus. Demand from emerging markets will continue to lift the company as patient populations grow and medical expertise improves, Chief Executive Officer Namal Nawana told Reuters.
- Simply Wall St.•2 months ago
Why Fundamental Investors Might Love Smith & Nephew plc (LON:SN.)
Attractive stocks have exceptional fundamentals. In the case of Smith & Nephew plc (LON:SN.), there's is a notable dividend-paying company that has been able to sustain great financial health over t...
- American City Business Journals•2 months ago
Quarterly office reports noted 'unprecedented interest' to be in Pittsburgh's fringe neighborhoods
New offices for Wabtec, Smith & Nephew and SAP helped stoke new office develop in the city's urban fringe
- Simply Wall St.•2 months ago
How Good Is Smith & Nephew plc (LON:SN.) At Creating Shareholder Value?
Today we'll look at Smith & Nephew plc (LON:SN.) and reflect on its potential as an investment. Specifically, we're going to calculate its Return On Capital Employed (ROCE), in the hopes of getting some insight into the business. F...
- American City Business Journals•2 months ago
London tech firm to open robotics R&D center at Stacks at 3 Crossings
London firm to take new space as first tenant at Stacks at 3 Crossings for the one-time Carnegie Mellon University robotic surgery spin off it bought for $275 million.
- Zacks•3 months ago
Here's Why You Should Invest in Smith & Nephew (SNN) Now
Smith & Nephew (SNN) has been gaining investor confidence on consistently positive results.
- Insider Monkey•3 months ago
Do Hedge Funds Love Smith & Nephew plc (SNN)?
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips. That outperformance comes with a price, however, as there are occasional periods of higher volatility. The fourth quarter of 2018 is one of those periods, as the Russell […]
- Simply Wall St.•3 months ago
How Much Money Does Smith & Nephew plc (LON:SN.) Make?
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! If you are currently a shareholder in Smith & Nephew plc (LON:SN.), or considering investing in the stock, you need to examin...
- Zacks•3 months ago
The Zacks Analyst Blog Highlights: Rio Tinto, Smith & Nephew, Endava, AstraZeneca and British American Tobacco
The Zacks Analyst Blog Highlights: Rio Tinto, Smith & Nephew, Endava, AstraZeneca and British American Tobacco
- GlobeNewswire•3 months ago
OSIRIS THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
WILMINGTON, Del., March 14, 2019 -- Rigrodsky & Long, P.A.: Do you own shares of Osiris Therapeutics, Inc. (NASDAQ GM: OSIR)? Did you purchase any of your shares prior to.
- Zacks•3 months ago
Is Britain Headed for a Soft Brexit? 5 Picks
Following May's fresh legislative defeat, Britain could exit the EU while retaining access to its common market.
